+
Open data
-
Basic information
| Entry | Database: PDB / ID: 7kfz | ||||||
|---|---|---|---|---|---|---|---|
| Title | Structure of a ternary KRas(G13D)-SOS complex | ||||||
Components |
| ||||||
Keywords | HYDROLASE/SIGNALING PROTEIN / Ras / Sos / GTPase / HYDROLASE-SIGNALING PROTEIN complex | ||||||
| Function / homology | Function and homology informationGTPase complex / Interleukin-15 signaling / Activation of RAC1 / neurotrophin TRK receptor signaling pathway / Signaling by LTK / leukocyte migration / Regulation of KIT signaling / epidermal growth factor receptor binding / NRAGE signals death through JNK / positive regulation of Rac protein signal transduction ...GTPase complex / Interleukin-15 signaling / Activation of RAC1 / neurotrophin TRK receptor signaling pathway / Signaling by LTK / leukocyte migration / Regulation of KIT signaling / epidermal growth factor receptor binding / NRAGE signals death through JNK / positive regulation of Rac protein signal transduction / response to mineralocorticoid / GMP binding / LRR domain binding / Fc-epsilon receptor signaling pathway / positive regulation of epidermal growth factor receptor signaling pathway / response to isolation stress / GRB2:SOS provides linkage to MAPK signaling for Integrins / response to gravity / myoblast proliferation / RET signaling / cardiac muscle cell proliferation / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / Role of LAT2/NTAL/LAB on calcium mobilization / RAS signaling downstream of NF1 loss-of-function variants / Interleukin receptor SHC signaling / RUNX3 regulates p14-ARF / Signal attenuation / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / Schwann cell development / SHC1 events in ERBB4 signaling / response to ischemia / Signalling to RAS / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / positive regulation of Ras protein signal transduction / myelination / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR4 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / insulin-like growth factor receptor signaling pathway / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / Signaling by CSF3 (G-CSF) / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / RAC1 GTPase cycle / FRS-mediated FGFR4 signaling / p38MAPK events / FRS-mediated FGFR1 signaling / Signaling by FGFR3 in disease / Tie2 Signaling / Signaling by FGFR2 in disease / protein-membrane adaptor activity / GRB2 events in EGFR signaling / Signaling by FLT3 fusion proteins / SHC1 events in EGFR signaling / FCERI mediated Ca+2 mobilization / FLT3 Signaling / EGFR Transactivation by Gastrin / Signaling by FGFR1 in disease / B cell receptor signaling pathway / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / liver development / axon guidance / guanyl-nucleotide exchange factor activity / GRB2 events in ERBB2 signaling / response to glucocorticoid / Downstream signal transduction / GTPase activator activity / Insulin receptor signalling cascade / SHC1 events in ERBB2 signaling / Antigen activates B Cell Receptor (BCR) leading to generation of second messengers / Constitutive Signaling by Overexpressed ERBB2 / Ras activation upon Ca2+ influx through NMDA receptor / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / VEGFR2 mediated cell proliferation / T cell activation / small monomeric GTPase / FCERI mediated MAPK activation / female pregnancy / SH3 domain binding / Signaling by ERBB2 TMD/JMD mutants / molecular condensate scaffold activity / Constitutive Signaling by EGFRvIII / Signaling by SCF-KIT / RAF activation / Signaling by high-kinase activity BRAF mutants / Signaling by ERBB2 ECD mutants Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3.47 Å | ||||||
Authors | Liu, C. / Moghadamchargari, Z. / Laganowsky, A. / Zhao, M. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Proc Natl Acad Sci U S A / Year: 2021Title: Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants. Authors: Zahra Moghadamchargari / Mehdi Shirzadeh / Chang Liu / Samantha Schrecke / Charles Packianathan / David H Russell / Minglei Zhao / Arthur Laganowsky / ![]() Abstract: Ras is regulated by a specific guanine nucleotide exchange factor Son of Sevenless (SOS), which facilitates the exchange of inactive, GDP-bound Ras with GTP. The catalytic activity of SOS is also ...Ras is regulated by a specific guanine nucleotide exchange factor Son of Sevenless (SOS), which facilitates the exchange of inactive, GDP-bound Ras with GTP. The catalytic activity of SOS is also allosterically modulated by an active Ras (Ras-GTP). However, it remains poorly understood how oncogenic Ras mutants interact with SOS and modulate its activity. Here, native ion mobility-mass spectrometry is employed to monitor the assembly of the catalytic domain of SOS (SOS) with KRas and three cancer-associated mutants (G12C, G13D, and Q61H), leading to the discovery of different molecular assemblies and distinct conformers of SOS engaging KRas. We also find KRas exhibits high affinity for SOS and is a potent allosteric modulator of its activity. A structure of the KRas•SOS complex was determined using cryogenic electron microscopy providing insight into the enhanced affinity of the mutant protein. In addition, we find that KRas-GTP can allosterically increase the nucleotide exchange rate of KRas at the active site more than twofold compared to KRas-GTP. Furthermore, small-molecule Ras•SOS disruptors fail to dissociate KRas•SOS complexes, underscoring the need for more potent disruptors. Taken together, a better understanding of the interaction between oncogenic Ras mutants and SOS will provide avenues for improved therapeutic interventions. | ||||||
| History |
|
-
Structure visualization
| Movie |
Movie viewer |
|---|---|
| Structure viewer | Molecule: Molmil Jmol/JSmol |
-
Downloads & links
-
Download
| PDBx/mmCIF format | 7kfz.cif.gz | 159.3 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb7kfz.ent.gz | 121.4 KB | Display | PDB format |
| PDBx/mmJSON format | 7kfz.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/kf/7kfz ftp://data.pdbj.org/pub/pdb/validation_reports/kf/7kfz | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 22857MC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | |
| EM raw data | EMPIAR-10894 (Title: Single-particle cryoEM data of a ternary KRas(G13D)-SOS complexData size: 3.7 TB Data #1: Unaligned raw movie of SOS-KRas (G13D) complex [micrographs - multiframe]) |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
| #1: Protein | Mass: 19386.848 Da / Num. of mol.: 2 / Mutation: G13D Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: KRAS, KRAS2, RASK2 / Production host: ![]() #2: Protein | | Mass: 57449.691 Da / Num. of mol.: 1 / Fragment: UNP residues 564-1049 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: SOS1 / Production host: ![]() #3: Chemical | ChemComp-GNP / | #4: Chemical | ChemComp-MG / | Has ligand of interest | N | |
|---|
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: A ternary complex of KRas(G13D) and SOScat / Type: COMPLEX / Entity ID: #1-#2 / Source: RECOMBINANT |
|---|---|
| Molecular weight | Value: 0.0967 MDa / Experimental value: YES |
| Source (natural) | Organism: Homo sapiens (human) |
| Source (recombinant) | Organism: ![]() |
| Buffer solution | pH: 7.4 |
| Specimen | Conc.: 8.6 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES |
| Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE / Humidity: 100 % / Chamber temperature: 281 K |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: FEI TITAN KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 105000 X / Nominal defocus max: 2500 nm / Nominal defocus min: 800 nm / Cs: 2.7 mm |
| Image recording | Electron dose: 65 e/Å2 / Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Num. of real images: 5202 |
-
Processing
| Software | Name: PHENIX / Version: 1.18.2_3874: / Classification: refinement | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EM software |
| ||||||||||||||||||||||||||||||||
| CTF correction | Type: PHASE FLIPPING ONLY | ||||||||||||||||||||||||||||||||
| Particle selection | Num. of particles selected: 5749548 | ||||||||||||||||||||||||||||||||
| Symmetry | Point symmetry: C1 (asymmetric) | ||||||||||||||||||||||||||||||||
| 3D reconstruction | Resolution: 3.47 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 1021288 / Symmetry type: POINT | ||||||||||||||||||||||||||||||||
| Atomic model building | B value: 50 / Protocol: AB INITIO MODEL / Space: REAL | ||||||||||||||||||||||||||||||||
| Atomic model building | PDB-ID: 1XD2 Accession code: 1XD2 / Source name: PDB / Type: experimental model | ||||||||||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi




Homo sapiens (human)
United States, 1items
Citation
UCSF Chimera
















PDBj






























